Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VDR | P11473 | 6/20 | 0.69 |
| ▸ | USP2 | O75604 | 2/20 | 0.69 |
| ▸ | GPBAR1 | Q8TDU6 | 4/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.68 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.68 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.68 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.68 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.68 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.68 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.68 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.68 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.68 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | CASP7 | P55210 | 3/20 | 0.67 |
| ▸ | TP53 | P04637 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22855097 | 1.00 | VDR (0.69) | VDRUSP2GPBAR1HSD17B10TDP1 | |
| SCHEMBL5891891 | 0.86 | GPBAR1 (0.70) | VDRUSP2GPBAR1HSD17B10TDP1 | |
| SCHEMBL29120311 | 0.85 | GPBAR1 (0.73) | VDRUSP2GPBAR1HSD17B10TDP1 | |
| SCHEMBL10385209 | 0.85 | GPBAR1 (0.73) | VDRUSP2GPBAR1HSD17B10TDP1 | |
| SCHEMBL19864253 | 0.85 | GPBAR1 (0.73) | VDRUSP2GPBAR1HSD17B10TDP1 | |
| SCHEMBL4624060 | 0.85 | GPBAR1 (0.73) | VDRUSP2GPBAR1HSD17B10TDP1 | |
| SCHEMBL18575773 | 0.85 | GPBAR1 (0.73) | VDRUSP2GPBAR1HSD17B10TDP1 | |
| SCHEMBL3125136 | 0.85 | GPBAR1 (0.73) | VDRUSP2GPBAR1HSD17B10TDP1 | |
| SCHEMBL30620024 | 0.85 | GPBAR1 (0.73) | VDRUSP2GPBAR1HSD17B10TDP1 | |
| SCHEMBL26670107 | 0.85 | GPBAR1 (0.73) | VDRUSP2GPBAR1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020260558-A1 | 3-MODIFIED ISO-/ISOALLO-LITHOCHOLIC ACID DERIVATIVES OR THEIR HOMO-ANALOGS FOR PREVENTING AND TREATING CLOSTRIDIOIDES DIFFICILE-ASSOCIATED DISEASES | PHENEX PHARMACEUTICALS AG (DE) | 2020-12-30 | — | — | WO | disclosed |
| US-20160326086-A1 | 4-HYDROXYBUTYRIC ACID ANALOGS | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2016-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160326086-A1 | 4-HYDROXYBUTYRIC ACID ANALOGS | HCRTR2, HCRTR1, HTR2B | VDR 2829/4885USP2 1927/4885GPBAR1 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.